| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lappe Rodney W serves as a Director at DSGN. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $1.9M at current prices.
Historically, Lappe Rodney W's trades have earned a below-average insider score of 41/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -4.9%.
The biggest single holding is DSGN (~$1.9M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 41,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2023 | DSGN Design Therapeutics, Inc. | Director | Buy | 21,000 | $2.35 | $49,287.00 | +18.7% | +16.9% | +125.8% | |
| Dec 9, 2022 | DSGN Design Therapeutics, Inc. | Director | Buy | 15,000 | $7.96 | $119,425.50 | +15.5% | -14.6% | -69.1% | |
| Mar 30, 2021 | DSGN Design Therapeutics, Inc. | Director | Buy | 5,000 | $20.00 | $100,000.00 | +5.4% | -22.5% | -45.8% |